Similar articles for PMID: 17577620

Year	Number of Results
2002	2
2003	2
2004	3
2005	3
2006	6
2007	15
2008	7
2009	15
2010	16
2011	13
2012	14
2013	10
2014	9
2015	12
2016	13
2017	8
2018	11
2019	7
2020	4
2021	2
2022	1
2024	0

1

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.

Barone C, Basso M, Schinzari G, Pozzo C, Trigila N, D'Argento E, Quirino M, Astone A, Cassano A. Barone C, et al. Gastric Cancer. 2007;10(2):104-11. doi: 10.1007/s10120-007-0415-x. Epub 2007 Jun 25. Gastric Cancer. 2007. PMID: 17577620 Clinical Trial.

2

Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2.

Turkeli M, Aldemir MN, Cayir K, Simsek M, Bilici M, Tekin SB, Yildirim N, Bilen N, Makas I. Turkeli M, et al. Asian Pac J Cancer Prev. 2015;16(3):985-9. doi: 10.7314/apjcp.2015.16.3.985. Asian Pac J Cancer Prev. 2015. PMID: 25735393 Free article.

3

A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer.

Kim KH, Park YS, Chang MH, Kim HS, Jun HJ, Uhm J, Yi SY, Lim DH, Ji SH, Park MJ, Lee J, Park SH, Park JO, Lim HY, Kang WK. Kim KH, et al. Cancer Chemother Pharmacol. 2009 Jul;64(2):347-53. doi: 10.1007/s00280-008-0878-4. Epub 2008 Dec 6. Cancer Chemother Pharmacol. 2009. PMID: 19066894 Clinical Trial.

4

A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.

Chen JS, Chen YY, Huang JS, Yeh KY, Chen PT, Shen WC, Hsu HC, Lin YC, Wang HM. Chen JS, et al. Gastric Cancer. 2012 Jan;15(1):49-55. doi: 10.1007/s10120-011-0060-2. Epub 2011 Jun 8. Gastric Cancer. 2012. PMID: 21655995 Clinical Trial.

5

Phase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimen.

Murad AM, Skare NG, Vinholes J, Lago S, Pecego R; Brazilian Gastric Cancer Study Group, Belo Horizonte, MG, Brazil. Murad AM, et al. Gastric Cancer. 2006;9(2):99-105. doi: 10.1007/s10120-006-0361-z. Gastric Cancer. 2006. PMID: 16767365 Clinical Trial.

6

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T. Cui Y, et al. Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52. doi: 10.1007/s00280-012-1991-y. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064955 Clinical Trial.

7

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.

Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Cancer Chemother Pharmacol. 2010 Jul;66(2):373-80. doi: 10.1007/s00280-009-1171-x. Epub 2009 Nov 21. Cancer Chemother Pharmacol. 2010. PMID: 19936751 Clinical Trial.

8

Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.

Kim JY, Ryoo HM, Bae SH, Kang BW, Chae YS, Yoon S, Baek JH, Kim MK, Lee KH, Lee SA, Song HS, Kim JG. Kim JY, et al. Anticancer Res. 2015 Jun;35(6):3531-6. Anticancer Res. 2015. PMID: 26026121 Clinical Trial.

9

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.

Choi YH, Oh SC, Kim JS, Nam SH, Kim BS, Cho SH, Chung IJ, Song EK, Yim CY, Baek JH, Jeung HC, Hong YS, Yang SH, Kang HJ. Choi YH, et al. Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72. doi: 10.1007/s00280-012-1956-1. Epub 2012 Aug 25. Cancer Chemother Pharmacol. 2012. PMID: 22926638 Clinical Trial.

10

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer.

Park KW, Ahn JS, Park YS, Lee J, Kang JH, Park JO, Lim HY, Im YH, Kang WK, Park K, Lee SI. Park KW, et al. Cancer Chemother Pharmacol. 2007 Jan;59(1):17-21. doi: 10.1007/s00280-006-0253-2. Epub 2006 May 24. Cancer Chemother Pharmacol. 2007. PMID: 16721549 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year